AntibioticResistance

Marc SilerWriting 39C

The Strategies to Address Antimicrobial Resistance Act (STAAR Act)

1. Decrease in R & D 2. Drug Misuse

3. No Surveillance 4. Lack of Understanding

10x‘20 Initiative (IDSA)

• Increase R&D programs• 10 new antibiotics by 2020

However…• Lengthy process• Very Costly• No guarantees of new drugs

10x‘20 Initiative (IDSA)

• Increase R&D programs• 10 new antibiotics by 2020

However…• Lengthy process• Very Costly• No guarantees of new drugs

The Strategies to Address Antimicrobial

Resistance Act

(S.2236)

Objectives

• Antimicrobial Resistance Office– Antimicrobial Task Force– Advisory Board

• Increase efforts of surveillance– Collecting data

• Strategic research plans

Costs• $600 million• If ineffective, lost time– Social, Medical, Political

Feasibility

• Initial Challenges- Compliance

• Possible

The Strategies to Address Antimicrobial

Resistance Act

(S.2236)

Works Cited• Antibiotic Resistance Threats. Rep. Center for Disease Control and Prevention, n.d.

Web. <http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf>.

• Antibiotic Resistance Timeline. Digital image. N.p., n.d. Web. 28 May 2014.• Bad Bugs, No Drugs. Rep. N.p.: n.p., n.d. Infectious Diseases Society of America,

July 2004. Web. 13 Apr. 2014. • Cancer Awareness Ribbon. Digital image. N.p., n.d. Web. 28 May 2014. • HIV Awareness Ribbon. Digital image. N.p., n.d. Web. 28 May 2014.• National Obesity Awareness Week Logo. Digital image. N.p., n.d. Web. 28 May

2014 • Red X. Digital image. N.p., n.d. Web. 28 May 2014.• Strategies to Address Antimicrobial Resistance, S. 2236, 113th Cong. (2014). Print.• "The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New

Antibacterial Drugs by 2020." Clinical Infectious Diseases 50.8 (2010): 1081-083. Clinical Infectious Diseases. Oxford Journals, 19 Feb. 2010. Web. 7 May 2014.